Networks
Networks
Challenges in developing effective treatments for idiopathic pulmonary fibrosis: Lessons from the ISABELA trials
Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease that affects an estimated 100,000 people in the United States alone.
Networks
Transitioning from pediatric to adult care
For young adults with chronic health conditions, the process of transitioning to adult health care is complicated, resulting in frustration for...
Networks
Lobar vs. sublobar resection in stage 1 lung cancer
Lobectomy with intrathoracic nodal dissection remains the standard of care for early stage NSCLC.
Networks
Beating jet lag at CHEST 2023
Before heading west to the meeting, Dr. Abbott recommends mainland USA travelers get extra light exposure in the evening.
Networks
The STELLAR Travel to BMPR2-based therapies for pulmonary arterial hypertension
Sotatercept improved 6-minute walk distance, the primary endpoint of the trial at 24 weeks,
Networks
RSV: Current patterns and future directions
Respiratory syncytial virus is an underappreciated cause of hospital admission in adult patients.
Networks
Sybil – Prophecies for lung cancer risk prediction?
The first 1 million “real world” patients screened in the US had very low (22%) annual adherence.
Networks
Home sleep apnea test: Peripheral arterial tonometry
Home sleep apnea test (HSAT) devices provide a cost effective, convenient method to diagnose OSA.
Networks
Emerging role of tele-rehab: Efficacy and challenges
On follow-up, only tele-PR participants had persistent improvements of CAT scores beyond 1 month after completion.
Networks
Replacing the Lung Allocation Score
In March 2023, the Composite Allocation Score will replace the Lung Allocation Score for matching donor lungs to transplant candidates in the...